Biotage AB (publ) (BITGF)
USD 11.5
(31.13%)
USD 11.5
(31.13%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 22.41 Million USD | 40.52% |
| 2022 | 15.94 Million USD | -25.72% |
| 2021 | 21.46 Million USD | 9.65% |
| 2020 | 19.57 Million USD | 67.31% |
| 2019 | 11.7 Million USD | -5.16% |
| 2018 | 12.33 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 150 Million USD | 964.96% |
| 2024 Q2 | 14.08 Million USD | -48.53% |
| 2024 Q1 | 27.36 Million USD | -6.64% |
| 2023 FY | 29.31 Million USD | 83.8% |
| 2023 Q3 | 27.99 Million USD | -0.87% |
| 2023 Q2 | 28.24 Million USD | 82.93% |
| 2023 Q4 | 29.31 Million USD | 4.7% |
| 2023 Q1 | 15.43 Million USD | -3.19% |
| 2022 Q2 | 19.38 Million USD | 21.67% |
| 2022 FY | 15.94 Million USD | -25.72% |
| 2022 Q4 | 15.94 Million USD | -12.41% |
| 2022 Q3 | 18.2 Million USD | -6.05% |
| 2022 Q1 | 15.92 Million USD | -25.8% |
| 2021 Q1 | 18.85 Million USD | 0.0% |
| 2021 Q4 | 21.46 Million USD | 301.4% |
| 2021 Q3 | 5.34 Million USD | -0.37% |
| 2021 Q2 | 5.36 Million USD | -71.53% |
| 2021 FY | 21.46 Million USD | 9.65% |
| 2020 FY | 19.57 Million USD | 67.31% |
| 2019 FY | 11.7 Million USD | -5.16% |
| 2018 FY | 12.33 Million USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 96.822% |
| Ansell Limited | 706.6 Million USD | 96.828% |
| BG Medicine, Inc. | - USD | -Infinity% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -3485.85% |
| ConvaTec Group Plc | 1.22 Billion USD | 98.171% |
| ConvaTec Group Plc | 1.22 Billion USD | 98.173% |
| Encision Inc. | 67.33 Thousand USD | -33183.181% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -5754.074% |
| LifePoint, Inc. | 151.73 Thousand USD | -14670.297% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -356.076% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -3544.157% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -12353.428% |
| SmileDirectClub, Inc. | 849.37 Million USD | 97.361% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 89.367% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -46119.891% |
| Vasamed, Inc. | 18.95 Thousand USD | -118166.823% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -121253.493% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -5640.005% |